12:00 AM
 | 
Apr 08, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Eisai sales and marketing update

Eisai launched NerBloc botulinum toxin type B intramuscular injection 2,500 unit in Japan to treat cervical dystonia. Each vial has a National Health Insurance (NHI) list price of ¥28,902 ($307). In 2000, Eisai received Japanese rights to the product from Elan Corp. plc (NYSE:ELN, Dublin, Ireland). In 2007, Solstice Neurosciences Inc. (Malvern, Pa.) granted...

Read the full 266 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >